More articles from Editorial
- Is there a doctor in your house? Home health care of the future
A modernized, efficient, effective home health care system would be a welcome improvement on the patchwork system we have had for the past 30 years.
- Timeliness of treatment is more important than choice of reperfusion therapy
The most important modifiable predictor of outcome in ST-segment elevation MI is the time to treatment, a biological truth that continues to be supported by clinical evidence.
- Stenting for atherosclerotic renal artery stenosis: One poorly designed trial after another
The three randomized trials of stenting vs medical therapy published so far are so seriously flawed that it is impossible to make treatment decisions based on their results.
- Treating the renal patient who has a fracture: Opinion vs evidence
The patient with chronic renal disease who has a fracture remains a unique management challenge. Opinions on treatment abound, but without adequate evidence to back them up.
- Should catheter ablation be the first line of treatment for atrial fibrillation?
Antiarrhythmic drugs should remain the first line of treatment until trials prove otherwise.
- The new data on prostate cancer screening: What should we do now?
Does screening have a benefit? We have new data, but do we have the answer?
- Evolution and results of aortic valve surgery, and a ‘disruptive’ technology
Percutaneous aortic valve insertion is already benefitting patients who would not be able to undergo open heart surgery for valve replacement. However, the technology is still so new that we do not yet know how to define who will benefit from it.
- Biochemical markers of bone turnover: Useful but underused
Markers tell us the risk of fracture and are useful in patient management. But will insurance pay for testing?
- Preventing renal disease progression: Can complete renin-angiotensin- aldosterone blockade work?
In view of the risks of complete blockade of the renin-angiotensin- aldosterone pathway, more data from clinical trials are needed before the general medical community widely applies this strategy to prevent progressive chronic kidney disease.